Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Middlefield Income Plus II Corp T.MIP

TSX:MIP - Post Discussion

Middlefield Income Plus II Corp > This is a long term investment
View:
Post by Cloud_Strife on Oct 19, 2007 6:42pm

This is a long term investment

Once Rudapine is approved by HC and used as a prescription drug for allergies next year then that'll be insane, everyone has allergies and the only prescription of allergy medicine is reactine i think, so we should do great, I'm going to ask for rudapine lol from my doctor; -that will be a great cashflow very consistent. Instillagel, is going to announce the quarterly profits attained next year I think, they sell them all across canada (HC approved) to hospitals and clinics, and those things are not cheap, about 3.28 british pounds each, and hospitals and clinics usually buy them in bulk.. I think they are also selling it across the world since HC approved it and they are done negotiating contracts with suppliers and have launched the product this quarter, if you type in Instillagel in google or something you can see the different suppliers than Mistral has licences to. The next quarter revenues should be very interesting...I've bought a ton of shares tried to clean up .035 cents as much as i can.. Bolduc has told me that he expects MIP to be in the mid-teens. Anyways, Pharmaceutical companies are good in the respect of mass distributions and sales among common people with common problems. We'll also finally be able to roll with consistent cashflow.... And it would just be a positive correlation from then on, profits are profits lol. Anyways, I like their pipeline, their NR's are all good, and yeah. That's what I know. So glta.
Comment by mrneutral on Oct 19, 2007 7:11pm
Thank you for the detailed reply and education. I appreciate it.
Comment by dvl99 on Oct 19, 2007 10:03pm
EXCELLENT review I bought alot between 3.5,4&4.5 and I'm staying for awhile.Just wait till they find someone to licence Unimin and BANG off to the races.There's just sooo much upside to this company
Comment by Cloud_Strife on Oct 19, 2007 10:21pm
Yeah I speak with the president a lot, I know that Dalal Manoli, the Vice President, Sales and Marketing person was waiting for Instillagel when it was approved by HC to finally market the crap out of Instillagel as it is our first global pipeline project (that's probably why she bought 5 million shares?), shes worked with a ton of pharmaceutical companies in marketing and sales in the past.  ...more  
Comment by dvl99 on Oct 19, 2007 11:23pm
We will get a full sales report only in june 08 since next quarter report will only have two weeks of sales
Comment by mrneutral on Oct 19, 2007 11:29pm
Since they are now moving into revenue generation mode, are there any market forcasts for this company yet or is it still considered a spec play? Thanks for all the good talk btw. I do appreciate it.
Comment by dvl99 on Oct 19, 2007 11:42pm
eresearch at .10 so far thats it.
Comment by Cloud_Strife on Oct 19, 2007 11:50pm
Hi Mr. xxxx, In fact, there will be some marketing costs incurred in Fiscal Q3 and following (to be reported in Feb 08), very low production costs only (margin is interesting). First sales (fiscal Q3) will be reported in Feb 08 with the main sales to be reported in Fiscal Q4 (results to be issued in June 08) Until that time, speculation on Instillagel’s sales will be just that ...more